OCM
EVH icon

Osterweis Capital Management’s Evolent Health EVH Stock Holding History

Osterweis Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-310,305
Closed -$8.78M – 201
2024
Q3 		$8.78M Buy
+310,305
New +$8M 0.44% 70
2017
Q4 		– Sell
-162,755
Closed -$2.9M – 105
2017
Q3 		$2.9M Buy
162,755
+45,150
+38% +$930K 0.22% 67
2017
Q2 		$2.98M Sell
117,605
-36,740
-24% -$884K 0.23% 56
2017
Q1 		$3.44M Buy
+154,345
New +$2.96M 0.27% 53

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Osterweis Capital Management's EVH Position: Q4 2024 in Review

Osterweis Capital Management sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 310,305 shares — an estimated $8.78M sold.

Osterweis Capital Management first reported a position in EVH in Q1 2017 and held it in 4 quarters. The position peaked at $8.78M in Q3 2024. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Osterweis Capital Management reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Osterweis Capital Management sold 310,305 Evolent Health shares in Q4 2024, an estimated $8.78M.
  • Osterweis Capital Management first reported a position in Evolent Health in Q1 2017 and held it in 4 quarters.
  • Osterweis Capital Management's Evolent Health position peaked at $8.78M in Q3 2024.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Osterweis Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.